These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 773842)

  • 1. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.
    van der Giessen M; Homan WL; van Kernbeek G; Aalberse RC; Dieges PH
    Int Arch Allergy Appl Immunol; 1976; 50(5):625-40. PubMed ID: 773842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy.
    Djurup R; Osterballe O
    Allergy; 1984 Aug; 39(6):433-41. PubMed ID: 6496881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization.
    Devey ME; Wilson DV; Wheeler AW
    Clin Allergy; 1976 May; 6(3):227-36. PubMed ID: 939035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between allergic status and specificity of IgG antibody to inhaled allergens: the grass pollen model.
    Michils A; Vervier I; Choufani G; Gossart B; Duchateau J
    Clin Exp Allergy; 1999 Jun; 29(6):832-9. PubMed ID: 10336601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies.
    Batard T; Basuyaux B; Laroze A; Lambin P; Brémard-Oury C; Aucouturier P; Hamilton RG; David B; Peltre G
    Int Arch Allergy Immunol; 1993; 102(3):279-87. PubMed ID: 8219781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG subclass antibody markers in grass pollen immunotherapy.
    Moss RB
    N Engl Reg Allergy Proc; 1987; 8(6):409-15. PubMed ID: 3325818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of grass pollen-specific IgE, IgA, IgM classes and IgG subclasses in allergic patients.
    Desvaux FX; Peltre G; David B
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):281-7. PubMed ID: 2759718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE, IgG and patient-self tests during slow hyposensitization to grass pollen.
    Blair H; Ezeoke A; Hobbs JR
    Clin Allergy; 1975 Sep; 5(3):263-70. PubMed ID: 1182987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-layer immunoradiometric assay for determination of IgG subclass antibodies in human sera ("IgG subclass RAST"). Validation of the subclass specificity, and establishment of equipotency.
    Djurup R; Søndergaard I; Magnusson CG; Weeke B
    Allergy; 1984 Jan; 39(1):51-63. PubMed ID: 6607688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subclass of IgG antibody in allergic disease: II. The IgG subclass of antibodies produced following natural exposure to dust mite and grass pollen in atopic and non-atopic individuals.
    Kemeny DM; Urbanek R; Ewan P; McHugh S; Richards D; Patel S; Lessof MH
    Clin Exp Allergy; 1989 Sep; 19(5):545-9. PubMed ID: 2790562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.
    Ejrnaes AM; Bodtger U; Larsen JN; Svenson M
    Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies between the skin test and IgE antibody assays: study of histamine release, complement activation in vitro, and occurrence of allergen-specific IgG.
    van der Zee JS; de Groot H; van Swieten P; Jansen HM; Aalberse RC
    J Allergy Clin Immunol; 1988 Aug; 82(2):270-81. PubMed ID: 3261308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy.
    Aberer W; Hawranek T; Reider N; Schuster C; Sturm G; Kränke B
    J Investig Allergol Clin Immunol; 2007; 17(3):131-6. PubMed ID: 17583098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy.
    Roberts AM; Van Ree R; Cardy SM; Bevan LJ; Walker MR
    Immunology; 1992 Jul; 76(3):389-96. PubMed ID: 1526648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy.
    Wachholz PA; Soni NK; Till SJ; Durham SR
    J Allergy Clin Immunol; 2003 Nov; 112(5):915-22. PubMed ID: 14610480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.